NM_080759.6:c.848+74805G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_080759.6(DACH1):c.848+74805G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.219 in 152,022 control chromosomes in the GnomAD database, including 4,427 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 4427 hom., cov: 32)
Consequence
DACH1
NM_080759.6 intron
NM_080759.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.26
Publications
2 publications found
Genes affected
DACH1 (HGNC:2663): (dachshund family transcription factor 1) This gene encodes a chromatin-associated protein that associates with other DNA-binding transcription factors to regulate gene expression and cell fate determination during development. The protein contains a Ski domain that is highly conserved from Drosophila to human. Expression of this gene is lost in some forms of metastatic cancer, and is correlated with poor prognosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DACH1 | ENST00000613252.5 | c.848+74805G>A | intron_variant | Intron 1 of 10 | 1 | NM_080759.6 | ENSP00000482245.1 | |||
| DACH1 | ENST00000619232.2 | c.848+74805G>A | intron_variant | Intron 1 of 11 | 5 | ENSP00000482797.1 | ||||
| DACH1 | ENST00000706274.1 | c.389+74805G>A | intron_variant | Intron 1 of 9 | ENSP00000516320.1 |
Frequencies
GnomAD3 genomes AF: 0.219 AC: 33316AN: 151904Hom.: 4428 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
33316
AN:
151904
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.219 AC: 33312AN: 152022Hom.: 4427 Cov.: 32 AF XY: 0.219 AC XY: 16289AN XY: 74290 show subpopulations
GnomAD4 genome
AF:
AC:
33312
AN:
152022
Hom.:
Cov.:
32
AF XY:
AC XY:
16289
AN XY:
74290
show subpopulations
African (AFR)
AF:
AC:
4125
AN:
41510
American (AMR)
AF:
AC:
3484
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
1089
AN:
3462
East Asian (EAS)
AF:
AC:
65
AN:
5178
South Asian (SAS)
AF:
AC:
769
AN:
4816
European-Finnish (FIN)
AF:
AC:
3300
AN:
10530
Middle Eastern (MID)
AF:
AC:
70
AN:
292
European-Non Finnish (NFE)
AF:
AC:
19755
AN:
67950
Other (OTH)
AF:
AC:
445
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1248
2495
3743
4990
6238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
288
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.